Solid State and Preclinical Development
Delivering exceptional services that lower costs, increase success rates, and reduce time to market for clients and patients
About
Solitek Pharma delivers decades of expertise in solid-state chemistry and preclinical development. Our integrated approach accelerates drug development while reducing costs and risks.
From initial solid form screening to advanced computational modeling, we provide comprehensive solutions that transform molecules into successful therapeutics.
Services
Comprehensive solid-state and preclinical development solutions designed to accelerate your drug development journey
Solid State Characterization
Comprehensive analysis of polymorphs, salts, and cocrystals to optimize drug substance properties
Solid Form Screening
Systematic screening and selection of optimal solid forms for development
Crystallization Process Development
Robust process development for scalable crystallization and purification
Early Enabling Formulation
Rapid formulation development for preclinical studies and first-in-human trials
Computational Solid-State
Advanced modeling and prediction of solid-state properties
Training and Consultancy
Expert guidance and training programs for your team
Products
Advanced pharmaceutical development platforms and tools
SolidForm™ Platform
Complete solid-state characterization and screening solutions
- • Polymorph screening
- • Salt/cocrystal selection
- • Stability assessment
CompSol™ Suite
Advanced computational modeling for solid-state prediction
- • Crystal structure prediction
- • Property modeling
- • Risk assessment
CrystPro™ Kit
Complete crystallization process development toolkit
- • Design of experiments
- • Process optimization
- • Scale-up protocols
Research
Cutting-edge research advancing solid-state chemistry and pharmaceutical development
Current Research Focus
AI-Powered Crystal Prediction
Machine learning models for predicting crystal structures and properties
Continuous Manufacturing
Research into continuous crystallization processes for improved efficiency
Amorphous Solid Dispersion
Novel approaches for enhancing bioavailability of poorly soluble drugs
Partners
Trusted by leading pharmaceutical companies and research institutions worldwide
Stephen Winter
Scientific Director
Víctor M. Díaz Pérez
Operations Director
Rosa María Espinosa
Lead Scientist
Joan Benet Congost
Technical Leader
Our partners benefit from our ISO 9001 certified quality management system and decades of expertise
Contact
Ready to accelerate your drug development? Let's discuss your project.